Freeline Therapeutics' Series A Round

Freeline Therapeutics raised a round of funding on December 10, 2015. Investors include Syncona Partners.

Freeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of gene therapies for bleeding and other debilitating disorders.…

Articles about Freeline Therapeutics' Series A Round: